Joshua Mitchell retweetledi
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects by Drs.
@mayocvonc, @joshmitchellmd et al.
An International Cardio-Oncology Society Position Statement:
jamanetwork.com/journals/jamao…
English
Joshua Mitchell
247 posts
Joshua Mitchell
@joshmitchellmd
Cardiologist at Washington University in St. Louis. #CardioOnc, evidence-based medicine, prevention, patient advocacy. Army veteran (#RLTW). Opinions my own.
St Louis, MO Katılım Nisan 2013
239 Takip Edilen459 Takipçiler
I am always in awe of the team we have on the @ICOSociety Scientific and Research Committee. Such a fantastic group of international collaborators. Really enjoyed working on this position statement with them. Great content in the manuscript and supplement!
#cardiooncology t.co/qagdk18h2E
International Cardio-Oncology Society@ICOSociety
📰 HOT OFF THE PRESSES 📰 Immune Checkpoint Inhibitor (#ICIs) treatments are known to potentially cause harm to the heart, particularly through conditions like #myocarditis. Today in @JAMAOnc, we stressed the importance of interdisciplinary collaboration as the best way to mitigate effects and protect the #hearts of #cancer patients. Read the positioning statement: jamanetwork.com/journals/jamao…
English
Joshua Mitchell retweetledi
Check out our publication in #CardioOncology. Atrial fibrillation/flutter in stem cell transplant patients. Prevalence, association with outcomes, and impact on healthcare resource-utilization/readmissions. @joshmitchellmd @Teebi_MD
rdcu.be/euXbx
English
@RajaZaghlol, a fantastic @WashUCardiology fellow, led this impactful study on afib in stem cell tx patients. Patients with afib were 3-4x more likely to die in the hospital, and 50% more likely to die in 90 days after discharge. Congrats! @ICOSociety #cardioonc
@SN_Oncology@SN_Oncology
🚨Recently published in #CardioOncology Atrial fibrillation or flutter in patients undergoing stem cell transplantation, in-hospital and post-discharge outcomes in a large nationwide sample across the United States🔍 #OpenAccess #CardiovascularHealth 👉doi.org/pvw8
English
Joshua Mitchell retweetledi
3 years ago my good friend @MorenoMDPhD approached me about this crazy idea to fill a much needed gap in heart failure education (1/3).
English
Congrats to Matt Lui, outstanding @WashUCardiology fellow, on his study showing that a visual review of CAC on NSCLC RAD planning CT was more predictive of CV events than Rad dose. Visual review ~ formal CAC score. #cardioonc @ICOSociety @SBRT_CR
link.springer.com/10.1186/s40959…
English
Congrats to @RajaZaghlol for leading our contemporary review of CV complications from radiation therapy including historic trends and current recs. Always great to work with @carmenbergom @DrLPedersen and @yoo_sgkyle! #cardioonc @WashUCardiology
authors.elsevier.com/a/1jze-2ct9A1t…
English
Congrats to @gwalls89 for an excellent manuscript detailing the practice patterns and general uptake of guidelines in #radonc internationally. Interesting insights! #cardioonc @icosociety @gerryhanna
doi.org/10.1016/j.clon…
English
Awesome work by @RajaZaghlol exploring the CV effects of CAR-T in the Medicare population. Well-deserved! Special thanks to @kejoynt, @dgermain21 and Elena Deych, among others as well! Looking forward to the manuscript! @WashUCardiology #cardioonc
Raja Zaghlol@RajaZaghlol
Proud to be selected as a YIA finalist in the #GCOS2024 presenting our work investigating MACE in older adults receiving CART therapy. Special thanks to @joshmitchellmd for exceptional mentoring. @ICOSociety
English
Joshua Mitchell retweetledi
Huge Congratulations w Thank you @JLiu_MSKCardOnc & @DrGuptaD! Phenomenal #MSKCardioOnc meeting moving #CardioOnc forward! @MSKCancerCenter @TeresaLpezFdez1 @drtarsh @dineshpmcc1 @Dr_Mike_Fradley @DrSFeldman @ninianlang @mayocvonc @joshmitchellmd @ICOSociety
Dipti Gupta MD, MPH@DrGuptaD
📢Agenda here! All ⭐️ line up of thought leaders #CardioOnc🗽Register today! @MSKCME @JLiu_MSKCardOnc @DrSFeldman @TomasNeilan @Dr_Mike_Fradley @AnaBaracCardio @TeresaLpezFdez1 @dineshpmcc1 @ninianlang @KHERA_MD @ParagGoyalMD
Queens, NY 🇺🇸 English
@DrSFeldman @MSKCME @genomics212 Thanks @DrSFeldman ! You have all planned an amazing symposium!!!! Glad I could contribute!
English
Masterful review of radiation heart disease and optimal strategies for surveillance by @joshmitchellmd #MSKCardioOncCME @MSKCME @genomics212
New York, NY 🇺🇸 English
Excellent symposium on #cardionc with a nice balance of presentations on the breadth of the field. Congrats to @JLiu_MSKCardOnc and @DrGuptaD and the rest of the planning committee. #mskcardionccme @MSKCancerCenter @WashUCardiology
Stephanie Feldman@DrSFeldman
Masterful review of radiation heart disease and optimal strategies for surveillance by @joshmitchellmd #MSKCardioOncCME @MSKCME @genomics212
English
Look forward to seeing everyone on Saturday for a packed agenda on #amyloidosis! Great speakers from @WUSTLmed and @PennMedicine as well as our esteemed grad @CampbellMDPhD! Free registration for trainees and patients/families.
@Amyloidosisfdn @CyclingDoctor @WashUCardiology
WashU Medicine Department of Medicine@WashUDeptMed
The Continuing Medical Education - Amyloidosis 2024: Update on Best Practices for Early Detection and Treatment - will be Saturday, April 27th. It's designed for healthcare providers involved in the diagnosis or management of amyloidosis. @WUSTLmed Info> l8r.it/AWoN
English
Great partnering with @myocardialsoln + the team on this important study. MRI myocardial strain is the most sensitive way to detect early cardiotoxicity. Excited to determine how early detection can best guide cardioprotection to improve heart health. @WashUCardiology #cardioonc
English
Joshua Mitchell retweetledi
Register now for @WUSTLmed @WUDeptMedicine Amyloidosis 2024 Symposium on April 27th- free for trainees! For details and to register, visit cme.wustl.edu/index.cfm?do=p…
English
Joshua Mitchell retweetledi
Excited to share this preprint. Serial, routine troponin-I screening in 428 consecutive patients treated with immunotherapy at our center was correlated with lower rates of grade 4-5 cardiovascular adverse events without a change in oncologic time on tx
medrxiv.org/content/10.110…
English
Joshua Mitchell retweetledi
Published in @Heart_BMJ --"Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society @ICOSociety statement"--an important step in improving care for our patients with #amyloidosis.
#CardioOnc @joshmitchellmd @WashUOnc #mmsm
heart.bmj.com/content/early/…
English
Great having the chance to talk #cardioonc education with @nickwilcox, @vgzmd, @BenedicteLefeb1 and @JACCJournals. Check out the podcast below. 👇
jacc.org/cardio-oncolog…
#jacccardioonc @WashUCardiology @WUSTLmed
English
Joshua Mitchell retweetledi
New Podcast from @JACCJournals Cardio-OncologyPulse featuring Dr. Joshua Mitchell, @joshmitchellmd highlighting education! @WUCardioFellows
jacc.org/cardio-oncolog…
English